Parathyroid hormone (English Wikipedia)

Barrett KE, Barman SM, Boitano S, Brooks H. "Chapter 23. Hormonal Control of Calcium & Phosphate Metabolism & the Physiology of Bone". In Barrett KE, Barman SM, Boitano S, Brooks H (eds.). Ganong's Review of Medical Physiology (23e ed.). Archived from the original on 7 July 2011. Retrieved 3 January 2016.

archive.org

Harrison TR, Adams RD, Bennett IL, Resnick WH, Thorn GW, Wintrobe MM (1958). "Metabolic and Endocrine Disorders". Principles of Internal Medicine (Third ed.). New York: McGraw-Hill Book Company. pp. 575–578.
Costanzo LS (2007). BRS Physiology. Lippincott, Williams, & Wilkins. pp. 260. ISBN 978-0-7817-7311-9.

clinchem.org

Bieglmayer C, Prager G, Niederle B (October 2002). "Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy". Clinical Chemistry. 48 (10): 1731–8. doi:10.1093/clinchem/48.10.1731. PMID 12324490. Archived from the original on 7 June 2011. Retrieved 23 February 2009.

doi.org

Brewer HB, Fairwell T, Ronan R, Sizemore GW, Arnaud CD (1972). "Human parathyroid hormone: amino-acid sequence of the amino-terminal residues 1-34". Proceedings of the National Academy of Sciences of the United States of America. 69 (12): 3585–8. Bibcode:1972PNAS...69.3585B. doi:10.1073/pnas.69.12.3585. PMC 389826. PMID 4509319.
Bieglmayer C, Prager G, Niederle B (October 2002). "Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy". Clinical Chemistry. 48 (10): 1731–8. doi:10.1093/clinchem/48.10.1731. PMID 12324490. Archived from the original on 7 June 2011. Retrieved 23 February 2009.
Jin L, Briggs SL, Chandrasekhar S, Chirgadze NY, Clawson DK, Schevitz RW, et al. (September 2000). "Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution". The Journal of Biological Chemistry. 275 (35): 27238–44. doi:10.1074/jbc.M001134200. PMID 10837469.
PDB: 1ETE; Savvides SN, Boone T, Andrew Karplus P (June 2000). "Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots". Nature Structural Biology. 7 (6): 486–91. doi:10.1038/75896. PMID 10881197.
Blaine J, Chonchol M, Levi M (2015). "Renal control of calcium, phosphate, and magnesium homeostasis". Clinical Journal of the American Society of Nephrology. 10 (7): 1257–72. doi:10.2215/CJN.09750913. PMC 4491294. PMID 25287933.
Brini M, Ottolini D, Calì T, Carafoli E (2013). "Chapter 4. Calcium in Health and Disease". In Sigel A, Roland HK (eds.). Interrelations between Essential Metal Ions and Human Diseases. Metal Ions in Life Sciences. Vol. 13. Springer. pp. 81–137. doi:10.1007/978-94-007-7500-8_4. ISBN 978-94-007-7499-5. PMID 24470090.
Coetzee M, Kruger MC (May 2004). "Osteoprotegerin-receptor activator of nuclear factor-kappaB ligand ratio: a new approach to osteoporosis treatment?". Southern Medical Journal. 97 (5): 506–11. doi:10.1097/00007611-200405000-00018. PMID 15180028. S2CID 45131847.
Poole KE, Reeve J (December 2005). "Parathyroid hormone - a bone anabolic and catabolic agent". Current Opinion in Pharmacology. 5 (6): 612–7. doi:10.1016/j.coph.2005.07.004. PMID 16181808.
Bord S, Ireland DC, Beavan SR, Compston JE (2003). "The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts". Bone. 32 (2): 136–41. doi:10.1016/S8756-3282(02)00953-5. PMID 12633785.
Sutters M, Gaboury CL, Bennett WM (1996). "Severe hyperphosphatemia and hypocalcemia: a dilemma in patient management". Journal of the American Society of Nephrology. 7 (10): 2056–61. doi:10.1681/ASN.V7102056. PMID 8915965.
Agus ZS (July 1999). "Hypomagnesemia". Journal of the American Society of Nephrology. 10 (7): 1616–22. doi:10.1681/ASN.V1071616. PMID 10405219.
Blaine J, Chonchol M, Levi M (July 2015). "Renal control of calcium, phosphate, and magnesium homeostasis". Clinical Journal of the American Society of Nephrology. 10 (7): 1257–72. doi:10.2215/CJN.09750913. PMC 4491294. PMID 25287933.
Carrillo-López N, Fernández-Martín JL, Cannata-Andía JB (1 April 2009). "[The role of calcium, calcitriol and their receptors in parathyroid regulation]". Nefrologia. 29 (2): 103–8. doi:10.3265/Nefrologia.2009.29.2.5154.en.full. PMID 19396314.
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. (May 2001). "Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis". The New England Journal of Medicine. 344 (19): 1434–41. doi:10.1056/NEJM200105103441904. PMID 11346808.
Kim ES, Keating GM (July 2015). "Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism". Drugs. 75 (11): 1293–303. doi:10.1007/s40265-015-0438-2. PMID 26177893. S2CID 2074875.
Watts NB, Bilezikian JP, Bone HG, Clarke BL, Denham D, Levine MA, et al. (March 2023). "Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism". Journal of the Endocrine Society. 7 (5): bvad043. doi:10.1210/jendso/bvad043. PMC 10119703. PMID 37091306.
Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, et al. (November 2007). "Teriparatide or alendronate in glucocorticoid-induced osteoporosis". The New England Journal of Medicine. 357 (20): 2028–39. doi:10.1056/NEJMoa071408. PMID 18003959.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000152266 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000059077 – Ensembl, May 2017

europa.eu

ema.europa.eu

"Preotact EPAR". European Medicines Agency. 17 September 2018. Retrieved 3 July 2020.
"Natpar EPAR". European Medicines Agency. 18 December 2013. Retrieved 28 December 2023. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

fda.gov

"FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism". U.S. Food and Drug Administration (FDA) (Press release). Archived from the original on 30 January 2015. Retrieved 30 January 2015. This article incorporates text from this source, which is in the public domain.

harvard.edu

ui.adsabs.harvard.edu

Brewer HB, Fairwell T, Ronan R, Sizemore GW, Arnaud CD (1972). "Human parathyroid hormone: amino-acid sequence of the amino-terminal residues 1-34". Proceedings of the National Academy of Sciences of the United States of America. 69 (12): 3585–8. Bibcode:1972PNAS...69.3585B. doi:10.1073/pnas.69.12.3585. PMC 389826. PMID 4509319.

labcorp.com

Parathyroid Hormone (PTH) Plus Calcium. LabCorp. Accessed 2019-07-02.

mft.nhs.uk

"Division of Laboratory Medicine: Parathyroid hormone" (PDF). Manchester University NHS Foundation Trust (UK). Archived from the original (PDF) on 2 February 2023. Retrieved 23 April 2022.

nih.gov

pubmed.ncbi.nlm.nih.gov

Khan M, Jose A, Sharma S (29 October 2022). "Physiology, Parathyroid Hormone". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 29763115. Retrieved 8 April 2025.
Brewer HB, Fairwell T, Ronan R, Sizemore GW, Arnaud CD (1972). "Human parathyroid hormone: amino-acid sequence of the amino-terminal residues 1-34". Proceedings of the National Academy of Sciences of the United States of America. 69 (12): 3585–8. Bibcode:1972PNAS...69.3585B. doi:10.1073/pnas.69.12.3585. PMC 389826. PMID 4509319.
Bieglmayer C, Prager G, Niederle B (October 2002). "Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy". Clinical Chemistry. 48 (10): 1731–8. doi:10.1093/clinchem/48.10.1731. PMID 12324490. Archived from the original on 7 June 2011. Retrieved 23 February 2009.
Jin L, Briggs SL, Chandrasekhar S, Chirgadze NY, Clawson DK, Schevitz RW, et al. (September 2000). "Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution". The Journal of Biological Chemistry. 275 (35): 27238–44. doi:10.1074/jbc.M001134200. PMID 10837469.
PDB: 1ETE; Savvides SN, Boone T, Andrew Karplus P (June 2000). "Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots". Nature Structural Biology. 7 (6): 486–91. doi:10.1038/75896. PMID 10881197.
Blaine J, Chonchol M, Levi M (2015). "Renal control of calcium, phosphate, and magnesium homeostasis". Clinical Journal of the American Society of Nephrology. 10 (7): 1257–72. doi:10.2215/CJN.09750913. PMC 4491294. PMID 25287933.
Brini M, Ottolini D, Calì T, Carafoli E (2013). "Chapter 4. Calcium in Health and Disease". In Sigel A, Roland HK (eds.). Interrelations between Essential Metal Ions and Human Diseases. Metal Ions in Life Sciences. Vol. 13. Springer. pp. 81–137. doi:10.1007/978-94-007-7500-8_4. ISBN 978-94-007-7499-5. PMID 24470090.
Coetzee M, Kruger MC (May 2004). "Osteoprotegerin-receptor activator of nuclear factor-kappaB ligand ratio: a new approach to osteoporosis treatment?". Southern Medical Journal. 97 (5): 506–11. doi:10.1097/00007611-200405000-00018. PMID 15180028. S2CID 45131847.
Poole KE, Reeve J (December 2005). "Parathyroid hormone - a bone anabolic and catabolic agent". Current Opinion in Pharmacology. 5 (6): 612–7. doi:10.1016/j.coph.2005.07.004. PMID 16181808.
Bord S, Ireland DC, Beavan SR, Compston JE (2003). "The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts". Bone. 32 (2): 136–41. doi:10.1016/S8756-3282(02)00953-5. PMID 12633785.
Haldimann B, Vogt K (1983). "[Hyperphosphatemia and tetany following phosphate enema]". Schweizerische Medizinische Wochenschrift (in French). 113 (35): 1231–3. PMID 6623048.
Sutters M, Gaboury CL, Bennett WM (1996). "Severe hyperphosphatemia and hypocalcemia: a dilemma in patient management". Journal of the American Society of Nephrology. 7 (10): 2056–61. doi:10.1681/ASN.V7102056. PMID 8915965.
Agus ZS (July 1999). "Hypomagnesemia". Journal of the American Society of Nephrology. 10 (7): 1616–22. doi:10.1681/ASN.V1071616. PMID 10405219.
Blaine J, Chonchol M, Levi M (July 2015). "Renal control of calcium, phosphate, and magnesium homeostasis". Clinical Journal of the American Society of Nephrology. 10 (7): 1257–72. doi:10.2215/CJN.09750913. PMC 4491294. PMID 25287933.
Carrillo-López N, Fernández-Martín JL, Cannata-Andía JB (1 April 2009). "[The role of calcium, calcitriol and their receptors in parathyroid regulation]". Nefrologia. 29 (2): 103–8. doi:10.3265/Nefrologia.2009.29.2.5154.en.full. PMID 19396314.
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. (May 2001). "Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis". The New England Journal of Medicine. 344 (19): 1434–41. doi:10.1056/NEJM200105103441904. PMID 11346808.
Kim ES, Keating GM (July 2015). "Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism". Drugs. 75 (11): 1293–303. doi:10.1007/s40265-015-0438-2. PMID 26177893. S2CID 2074875.
Watts NB, Bilezikian JP, Bone HG, Clarke BL, Denham D, Levine MA, et al. (March 2023). "Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism". Journal of the Endocrine Society. 7 (5): bvad043. doi:10.1210/jendso/bvad043. PMC 10119703. PMID 37091306.
Riek AE, Towler DA (2011). "The pharmacological management of osteoporosis". Missouri Medicine. 108 (2): 118–23. PMC 3597219. PMID 21568234.
Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, et al. (November 2007). "Teriparatide or alendronate in glucocorticoid-induced osteoporosis". The New England Journal of Medicine. 357 (20): 2028–39. doi:10.1056/NEJMoa071408. PMID 18003959.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Khan M, Jose A, Sharma S (29 October 2022). "Physiology, Parathyroid Hormone". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 29763115. Retrieved 8 April 2025.
Brewer HB, Fairwell T, Ronan R, Sizemore GW, Arnaud CD (1972). "Human parathyroid hormone: amino-acid sequence of the amino-terminal residues 1-34". Proceedings of the National Academy of Sciences of the United States of America. 69 (12): 3585–8. Bibcode:1972PNAS...69.3585B. doi:10.1073/pnas.69.12.3585. PMC 389826. PMID 4509319.
Blaine J, Chonchol M, Levi M (2015). "Renal control of calcium, phosphate, and magnesium homeostasis". Clinical Journal of the American Society of Nephrology. 10 (7): 1257–72. doi:10.2215/CJN.09750913. PMC 4491294. PMID 25287933.
Blaine J, Chonchol M, Levi M (July 2015). "Renal control of calcium, phosphate, and magnesium homeostasis". Clinical Journal of the American Society of Nephrology. 10 (7): 1257–72. doi:10.2215/CJN.09750913. PMC 4491294. PMID 25287933.
Watts NB, Bilezikian JP, Bone HG, Clarke BL, Denham D, Levine MA, et al. (March 2023). "Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism". Journal of the Endocrine Society. 7 (5): bvad043. doi:10.1210/jendso/bvad043. PMC 10119703. PMID 37091306.
Riek AE, Towler DA (2011). "The pharmacological management of osteoporosis". Missouri Medicine. 108 (2): 118–23. PMC 3597219. PMID 21568234.

dailymed.nlm.nih.gov

"Natpara (parathyroid hormone)- parathyroid hormone injection, powder, lyophilized, for solution". DailyMed. Retrieved 8 May 2021.
"Forteo- teriparatide injection, solution". DailyMed. 29 April 2021. Archived from the original on 19 January 2022. Retrieved 8 March 2023.

nlm.nih.gov

Zieve D. "MedlinePlus Medical Encyclopedia: Serum calcium". National Library of Medicine, National Institutes of Health. Retrieved 1 February 2009.

parathyroid.com

"Symptoms of Hyperparathyroidism and Symptoms of Parathyroid Disease". Parathyroid.com. Norman Parathyroid Center. Retrieved 30 December 2015.

pharmatimes.com

PharmaTimes (13 June 2006). "NPS plummets on decision to halt Preos development - PharmaTimes". pharmatimes.com. Retrieved 24 April 2025.

questdiagnostics.com

testdirectory.questdiagnostics.com

PTH, Intact and Calcium Test Detail. Quest Diagnostics Lab. Accessed 2019-06-29.

rcsb.org

PDB: 1ETE; Savvides SN, Boone T, Andrew Karplus P (June 2000). "Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots". Nature Structural Biology. 7 (6): 486–91. doi:10.1038/75896. PMID 10881197.

revistanefrologia.com

Carrillo-López N, Fernández-Martín JL, Cannata-Andía JB (1 April 2009). "[The role of calcium, calcitriol and their receptors in parathyroid regulation]". Nefrologia. 29 (2): 103–8. doi:10.3265/Nefrologia.2009.29.2.5154.en.full. PMID 19396314.

semanticscholar.org

api.semanticscholar.org

Coetzee M, Kruger MC (May 2004). "Osteoprotegerin-receptor activator of nuclear factor-kappaB ligand ratio: a new approach to osteoporosis treatment?". Southern Medical Journal. 97 (5): 506–11. doi:10.1097/00007611-200405000-00018. PMID 15180028. S2CID 45131847.
Kim ES, Keating GM (July 2015). "Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism". Drugs. 75 (11): 1293–303. doi:10.1007/s40265-015-0438-2. PMID 26177893. S2CID 2074875.

takeda.com

"Takeda Issues US Recall of NATPARA® (parathyroid hormone) for Injection Due to the Potential for Rubber Particulate". www.takeda.com. Retrieved 24 April 2025.
"Takeda to Discontinue Manufacturing of NATPAR® / NATPARA® for Patients with Hypoparathyroidism at the End of 2024". www.takeda.com. Retrieved 24 April 2025.

tuars.com

humanphysiology.tuars.com

Nosek TM. "Section 5/5ch6/s5ch6_11". Essentials of Human Physiology. Archived from the original on 24 March 2016.

unitslab.com

"Parathyroid hormone (PTH) unit conversion (online calculator)". Unitslab.

web.archive.org

Nosek TM. "Section 5/5ch6/s5ch6_11". Essentials of Human Physiology. Archived from the original on 24 March 2016.
Bieglmayer C, Prager G, Niederle B (October 2002). "Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy". Clinical Chemistry. 48 (10): 1731–8. doi:10.1093/clinchem/48.10.1731. PMID 12324490. Archived from the original on 7 June 2011. Retrieved 23 February 2009.
Barrett KE, Barman SM, Boitano S, Brooks H. "Chapter 23. Hormonal Control of Calcium & Phosphate Metabolism & the Physiology of Bone". In Barrett KE, Barman SM, Boitano S, Brooks H (eds.). Ganong's Review of Medical Physiology (23e ed.). Archived from the original on 7 July 2011. Retrieved 3 January 2016.
"Division of Laboratory Medicine: Parathyroid hormone" (PDF). Manchester University NHS Foundation Trust (UK). Archived from the original (PDF) on 2 February 2023. Retrieved 23 April 2022.
"FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism". U.S. Food and Drug Administration (FDA) (Press release). Archived from the original on 30 January 2015. Retrieved 30 January 2015. This article incorporates text from this source, which is in the public domain.
"Forteo- teriparatide injection, solution". DailyMed. 29 April 2021. Archived from the original on 19 January 2022. Retrieved 8 March 2023.

wikipathways.org

The interactive pathway map can be edited at WikiPathways: "VitaminDSynthesis_WP1531".